Print page

IMMURON LIMITED (IMC)

On this page you will find:

Delayed share price		Company details
Company announcements		Closing prices
Price history chart		Dividends
Exchange Traded Options		Warrants & Structured Products
		ASX CFDs

Delayed share price

Prices are delayed by at least 20 minutes. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
IMC	0.083	0%	0.083	0.088	0.083	0.083	0.083	97,000

IMMURON LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	IMC
Securities
Official Listing Date	30 April, 1999
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.immuron.com
Registered Office Address	Level 1, 39 Leveson Street, NORTH MELBOURNE, VIC, AUSTRALIA, 3051
Head Office Telephone	03 9018 4880
Head Office Fax	03 9018 4881
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone	1300 787 272

Directors / Senior Management
Prof. Colin Chapman (Executive Chairman, Non Exec. Director) Dr Grant Rawlin (CEO) Prof. Roy Robins-Browne (Director, Non Exec. Director) Dr Elane Zelcer (Director) Mr Simon Salka (Non Exec. Director) Mr Graeme Stevens (CFO)

Company Secretary	Mr Graeme Stevens

IMMURON LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Headline	Pages	PDF
01/09/2010	NASH Clinical trial results presentation at Internat. Confer	2	PDF
31/08/2010	Preliminary Final Report	3	PDF
31/08/2010	Full Year Statutory Accounts 30 June 2010	57	PDF
23/08/2010	Successful Results from NASH Clinical Trial	2	PDF
02/08/2010	Appendix 3B Share issue 2 August 2010	7	PDF
21/07/2010	Appendix 3B- share issue 21 July 2010	7	PDF
07/07/2010	Ceasing to be a substantial holder	2	PDF
05/07/2010	Capital raising and current top 20 shareholders	2	PDF
02/07/2010	Notice under Section 708A (5) of Corporations Act 2001	1	PDF
01/07/2010	Change of Director`s Interest Notice- Form 3Y - E Zelcer	3	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
08 Sep 2010	0.083	-7.78%	0.088	0.083	180,000
07 Sep 2010	0.090	0%	0.090	0.090	30,000
03 Sep 2010	0.090	0%	0.090	0.087	414,713
02 Sep 2010	0.090	-5.26%	0.090	0.090	180,000
01 Sep 2010	0.095	-4.04%	0.095	0.095	40,000

* Volume of shares shown represents only those shares traded on ASX.

IMMURON LIMITED price history chart

ASX excludes all liability arising out of any inaccuracies in this chart, except where liability is made non-excludable by legislation. Chart values may be adjusted for changes in a company's capital structure or to link historical values that represent the company's primary equity security. Explanation of chart terms.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security IMC. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No options are available over the security IMC

Warrants & Structured Products

No warrants & Structured Products are available over the security IMC

ASX CFDs

No Contracts For Differences are available over the security IMC

Company information lookup